Fc receptors (CD16) facilitate antibody-dependent cytotoxicity (ADCC), while tumor-associated CD112 and CD155 interact with DNAM-1 to enhance NK cytotoxicity inside the tumor microenvironment. This evidence concerns the gene CD226 and neoplasm.